108 related articles for article (PubMed ID: 1671526)
1. The effects of dynorphin A (1-13) and U50, 488H on free intracellular calcium in guinea pig cerebellar synaptosomes.
Olson KG; Welch SP
Life Sci; 1991; 48(6):575-81. PubMed ID: 1671526
[TBL] [Abstract][Full Text] [Related]
2. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
Touzeau PL; Shea-Donohue T
J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
[TBL] [Abstract][Full Text] [Related]
3. Chronic U50,488H abolishes inositol 1,4,5-trisphosphate and intracellular Ca2+ elevations evoked by kappa-opioid receptor in rat myocytes.
Sheng JZ; Wong TM
Eur J Pharmacol; 1996 Jul; 307(3):323-9. PubMed ID: 8836621
[TBL] [Abstract][Full Text] [Related]
4. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
Brent PJ
Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
[TBL] [Abstract][Full Text] [Related]
5. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
Zhou JJ; Bian JS; Pei JM; Wu S; Li HY; Wong TM
Br J Pharmacol; 2002 Apr; 135(7):1675-84. PubMed ID: 11934807
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
Rochford J; Godin C; Henry JL
Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
8. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
[TBL] [Abstract][Full Text] [Related]
9. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals.
Gannon RL; Terrian DM
Brain Res; 1991 May; 548(1-2):242-7. PubMed ID: 1678297
[TBL] [Abstract][Full Text] [Related]
10. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
[TBL] [Abstract][Full Text] [Related]
11. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
12. kappa-Opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes.
Tai KK; Bian CF; Wong TM
Life Sci; 1992; 51(12):909-13. PubMed ID: 1355576
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
14. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
Nencini P; Stewart J
Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
[TBL] [Abstract][Full Text] [Related]
15. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
Shen KF; Crain SM
Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures.
Kong LY; McMillian MK; Hudson PM; Jin L; Hong JS
J Pharmacol Exp Ther; 1997 Jan; 280(1):61-6. PubMed ID: 8996182
[TBL] [Abstract][Full Text] [Related]
17. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
Zhao Y; Joshi AA; Aldrich JV; Murray TF
Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
[TBL] [Abstract][Full Text] [Related]
18. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
19. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
20. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
Bian JS; Pei JM; Cheung CS; Zhang WM; Wong TM
J Mol Cell Cardiol; 2000 Aug; 32(8):1415-27. PubMed ID: 10900168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
